Latest Derivatives News

Ark Mines has produced high-grade monazite and titanium dioxide products from its Sandy Mitchell heavy mineral concentrate, marking a key step toward commercialising its North Queensland rare earths project.

Delorean Corporation’s SA1 Salisbury bioenergy project has secured accreditation under GreenPower’s Renewable Gas Certification, enabling it to issue Renewable Gas Guarantee of Origin certificates and strengthen its role in Australia’s renewable gas market.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.

Greenvale Energy has completed initial product assessments for its Alpha Project bitumen samples, successfully separating volatile fractions and producing a bitumen-like material. The company plans further processing to meet industry specifications and awaits independent certification.

Ovanti Limited has inked a four-year exclusive partnership with Yuno.trade, positioning itself as the payment processor and technology backbone for a new licensed prediction market platform targeting Southeast and Central Asia.

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

Aldoro Resources has achieved a major metallurgical milestone at its Kameelburg project, with direct acid leach tests recovering up to 72% of rare earth elements and over 99% of strontium without prior beneficiation, suggesting a potentially lower-cost development pathway.

Aureka Limited's latest high-resolution drone magnetic survey over its Irvine Gold Project has unveiled several new high-priority exploration targets, with ongoing diamond drilling aimed at expanding its 304koz JORC resource. The engagement of renowned geologist Dr Barry Murphy signals a strategic push to decode the project's complex structural geology.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

FMR Resources has received final assays from drillhole 26LHDD073 at its Southern Porphyry target, confirming extensive copper-gold-molybdenum mineralisation and supporting the interpretation of a large porphyry system. Ongoing integration of geological and geophysical data aims to refine targets ahead of Phase II drilling.

Strategic Elements Ltd has received $1.2 million in applications under its Share Purchase Plan, surpassing its initial $1 million target and raising the cap to $2.5 million. The extra funds will accelerate development of its moisture-powered Energy Ink™ and operational intelligence platform EdgeiQ™.